Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Sales | 2,567 | 3,224 | 2,543 | 2,182 | 2,221 |
| Cost of Goods | 3,770 | 3,640 | 2,820 | 3,610 | 2,950 |
| Gross Profit | -1,200 | -420 | -290 | -1,420 | -730 |
| Operating Expenses | 2,640 | 2,630 | 3,910 | 2,590 | 2,800 |
| Operating Income | -3,073 | -2,406 | -3,367 | -3,408 | -2,579 |
| Interest Expense | 970 | 850 | 460 | 520 | 530 |
| Other Income | 33 | -24 | -93 | 8 | -11 |
| Pre-tax Income | -4,010 | -3,280 | -3,920 | -3,920 | -3,120 |
| Net Income Continuous | -4,010 | -3,282 | -3,963 | -3,926 | -3,054 |
| Net Income | $-4,010 | $-3,282 | $-3,963 | $-3,926 | $-3,054 |
| EPS Basic Total Ops | -14.00 | -11.50 | -14.00 | -14.00 | -11.00 |
| EPS Basic Continuous Ops | -14.03 | -11.51 | -14.17 | -14.23 | -11.09 |
| EPS Diluted Total Ops | -14.00 | -11.50 | -14.00 | -14.00 | -11.00 |
| EPS Diluted Continuous Ops | -14.05 | -11.51 | -14.17 | -14.23 | -11.09 |
| EBITDA(a) | $-2,743 | $-2,086 | $-2,867 | $-2,948 | $-2,059 |